SINEMET FDA MedWatch Direct Reports Summary
These tables and charts are created from 290 voluntary U.S. reports for SINEMET (CARBIDOPA\LEVODOPA) reported by individuals to the FDA via the MedWatch Reporting System from 2004 through April 28, 2026.
For a summary of adverse events including mandatory reports submitted by pharmaceutical companies (all countries and all reporter types) to the FAERS database, View FDA FAERS SINEMET Report.
Top Adverse Effects Associated with SINEMET (from U.S. FDA Medwatch Reports)
Side Effect # of FDA Reports 1 DEATH 38 2 HALLUCINATION 17 3 LACK OF STRENGTH AND ENERGY (ASTHENIA) 16 4 FALL 16 5 FATIGUE 16 6 CONFUSIONAL STATE 13 7 DRUG INEFFECTIVE 12 8 GAIT DISTURBANCE 12 9 NAUSEA 12 10 DIZZINESS 11 11 URINARY TRACT INFECTION 10 12 CONDITION AGGRAVATED 9 13 PARKINSON^S DISEASE 9 14 PRODUCT SUBSTITUTION ISSUE 9 15 DYSKINESIA 8 16 DROWSINESS 8 17 STROKE 7 18 DISEASE PROGRESSION 7 19 TREMOR 7 20 VOMITING 7 21 DEHYDRATION 6 22 FEELING ABNORMAL 6 23 LOW BLOOD PRESSURE 6 24 LETHARGY 6 25 MALAISE 6
SINEMET Total Medwatch Safety Reports by Patient Sex
| Male | Female | Unknown | Total |
|---|---|---|---|
| 140 | 123 | 27 | 290 |
| Medwatch Reporter Type | Count |
| Consumer | 100 |
| Physician | 14 |
| Pharmacist | 74 |
| Other Health Professional | 54 |
| Top Indications | |
| Parkinson's disease | |
| Product used for unknown indication | |
| Parkinsonism | |
| Extrapyramidal disorder | |
Type of Outcome Reported
Serious: 219
Not Serious: 71
Note: A serious outcome means the adverse event resulted in death, a life threatening condition, hospitalization, disability, congenital anomaly, or other serious condition.
Suspected Role
Primary Suspect: 290
Concomitant Drugs: 251
Note: A single MedWatch report can list more than one drug. This summary includes SINEMET identified as the suspect drug or as a concomitantly taken drug.
FDA Safety-Related Labeling Changes
SINEMET (LEVODOPA; CARBIDOPA) Rx Drug:
FDA Safety Communication
May cause Vitamin B6 deficiency, leading to seizures.
SINEMET (LEVODOPA; CARBIDOPA) Rx Drug:
FDA Safety-related Labeling Changes
Carbidoba/Levodopa may cause Vitamin B6 deficiency, leading to seizures.
Have experience (good or bad) with SINEMET? Rate SINEMET at Ask a Patient.
For serious adverse events, report them to the FDA by contacting the drug manufacturer or report directly through the MedWatch voluntary reporting form.
NOTES
This report, created by AskaPatient.com, is derived from U.S. drug-related adverse event cases that were reported directly to the FDA using the voluntary MedWatch online or paper reporting system. MedWatch is the voluntary FDA system for consumers, physicians, and others to directly report adverse reactions. The Medwatch initiative was launched in 1993 as a voluntary reporting program for consumers, physicians and other healthcare practitioners.
After processing the received forms, the FDA adds the MedWatch reports to the FDA Adverse Events Reporting System(or FAERS database.) Click here for the complete FAERS report summary, which includes mandatory reports submitted by pharmaceutical companies (worldwide) combined with the MedWatch reports. MedWatch Reports only represent about 5% of the FAERS database. For more, read "Does the FDA's Rapidly Growing Database of Adverse Events Improve Drug Safety?"
The data in this report was obtained from Open FDA. Data was last updated to include reports through January 27, 2026. The reactions, side effects, or "adverse events," represent up to the 20 most frequently occuring events in the database for a drug related to the event.
Open FDA states that it only includes the most recent version of a case report. It also adds the disclaimer: "Do not rely on Open FDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated."
FDA uses the "MedDRA" classification system to describe reported adverse
reactions. MedDRA is a standardized medical terminology that facilitates
sharing of regulatory information internationally. In some cases, "patient
friendly" terms for the layman designated by MedDRA have been substituted
for medical jargon. Please
contact us
with questions about this report.
